Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells-Reference-Cited by-同舟云学术

Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells

Published:2011-02-19 Issue:1 Volume:131 Page:49-63
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Courtin Aurélie,Communal Laudine,Vilasco Myriam,Cimino Daniela,Mourra Najat,de Bortoli Michele,Taverna Daniela,Faussat Anne-Marie,Chaouat Marc,Forgez Patricia,Gompel Anne

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-011-1394-5.pdf

Reference47 articles.

1. Rossouw JE, Anderson GL, Prentice RL et al (2002) Risks and benefits of estrogen plus progestogen in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 288:321–333

2. Fournier A, Berrino F, Clavel-Chapelon F (2008) Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat 107:103–111

3. Bakken K, Fournier A, Lund E et al (2011) Menopausal hormone therapy and breast cancer risk: Impact of different treatments. The European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 128:144–156

4. Calle EE, Feigelson HS, Hildebrand JS et al (2009) Postmenopausal hormone use and breast cancer associations differ by hormone regimen and histologic subtype. Cancer 115:936–945

5. Sitruk-Ware R (2008) Pharmacological profile of progestogens. Maturitas 61:151–157

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between menopausal hormone therapy and breast cancer: A nationwide population‐based cohort study;International Journal of Gynecology & Obstetrics;2024-03-12

2. Adaptive, reversible, hypothalamic reproductive suppression: More than functional hypothalamic amenorrhea;Frontiers in Endocrinology;2022-10-19

3. Maternal-fetal conflict averted by progesterone- induced FOXP3+ regulatory T cells;iScience;2022-06

4. Therapeutic Strategies and Potential Actions of Female Sex Steroid Hormones and Their Receptors in Colon Cancer Based on Preclinical Studies;Life;2022-04-18

5. PGRMC1 Promotes Progestin-Dependent Proliferation of Breast Cancer Cells by Binding Prohibitins Resulting in Activation of ERα Signaling;Cancers;2021-11-11